Dynavax Technologies (DVAX) Short Interest Ratio & Short Volume $10.16 +0.10 (+0.99%) Closing price 04:00 PM EasternExtended Trading$10.16 0.00 (0.00%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Dynavax Technologies Short Interest DataDynavax Technologies (DVAX) has a short interest of 15.17 million shares, representing 13.26% of the float (the number of shares available for trading by the public). This marks a -3.99% decrease in short interest from the previous month. The short interest ratio (days to cover) is 6.7, indicating that it would take 6.7 days of the average trading volume of 2.16 million shares to cover all short positions.Current Short Interest15,170,000 sharesPrevious Short Interest15,800,000 sharesChange Vs. Previous Month-3.99%Dollar Volume Sold Short$155.80 millionShort Interest Ratio6.7 Days to CoverLast Record DateJune 15, 2025Outstanding Shares120,080,000 sharesFloat Size114,400,000 sharesShort Percent of Float13.26%Today's Trading Volume1,431,186 sharesAverage Trading Volume2,161,195 sharesToday's Volume Vs. Average66% Short Selling Dynavax Technologies? Sign up to receive the latest short interest report for Dynavax Technologies and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartDVAX Short Interest Over TimeDVAX Days to Cover Over TimeDVAX Percentage of Float Shorted Over Time Dynavax Technologies Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/202515,170,000 shares $155.80 million -4.0%13.3%6.7 $10.27 5/31/202515,800,000 shares $155.00 million +3.0%13.8%6.8 $9.81 5/15/202515,340,000 shares $145.88 million -21.8%13.4%5.8 $9.51 4/30/202519,610,000 shares $230.42 million +9.8%17.1%7.5 $11.75 4/15/202517,860,000 shares $203.78 million -2.9%14.0%7.3 $11.41 3/31/202518,400,000 shares $238.65 million -2.9%14.4%7.8 $12.97 3/15/202518,950,000 shares $262.84 million +0.1%14.9%8.9 $13.87 2/28/202518,940,000 shares $261.18 million -5.5%14.9%9.4 $13.79 2/15/202520,040,000 shares $256.91 million +3.1%15.7%11.9 $12.82 1/31/202519,440,000 shares $253.69 million +1.4%N/A9.9 $13.05 Get the Latest News and Ratings for DVAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dynavax Technologies and its competitors with MarketBeat's FREE daily newsletter. 1/15/202519,170,000 shares $239.24 million +11.9%N/A8.9 $12.48 12/31/202417,130,000 shares $218.75 million +2.1%N/A7.8 $12.77 12/15/202416,780,000 shares $217.47 million -6.3%N/A8 $12.96 11/30/202417,900,000 shares $230.19 million -14.8%N/A8.2 $12.86 11/15/202421,000,000 shares $256.41 million +11.5%N/A9.2 $12.21 10/31/202418,840,000 shares $223.25 million +10.4%N/A9 $11.85 10/15/202417,060,000 shares $183.57 million +0.1%N/A8.3 $10.76 9/30/202417,040,000 shares $189.83 million -5.6%N/A8.5 $11.14 9/15/202418,050,000 shares $201.62 million -1.4%N/A8.6 $11.17 8/31/202418,300,000 shares $205.33 million -3.3%N/A8.3 $11.22 8/15/202418,930,000 shares $214.67 million +5.8%N/A8.5 $11.34 7/31/202417,890,000 shares $200.19 million +4.0%N/A7.7 $11.19 7/15/202417,210,000 shares $181.74 million -4.7%N/A8 $10.56 6/30/202418,060,000 shares $202.81 million -18.1%N/A8 $11.23 6/15/202422,060,000 shares $254.79 million +3.1%N/A10.4 $11.55 5/31/202421,390,000 shares $256.47 million -5.8%N/A10.2 $11.99 5/15/202422,700,000 shares $250.61 million +15.7%N/A11 $11.04 4/30/202419,620,000 shares $223.08 million +5.8%N/A10 $11.37 4/15/202418,540,000 shares $216.73 million +3.2%N/A9.6 $11.69 3/31/202417,970,000 shares $223.01 million +3.6%N/A9.2 $12.41 3/15/202417,350,000 shares $209.07 million +6.0%N/A8.9 $12.05 2/29/202416,370,000 shares $207.41 million +9.1%N/A8.6 $12.67 2/15/202415,000,000 shares $187.20 million +4.7%N/A8 $12.48 1/31/202414,330,000 shares $185.14 million -1.2%N/A8 $12.92 1/15/202414,510,000 shares $202.12 million -2.9%13.9%8.1 $13.93 12/31/202314,950,000 shares $209.00 million +1.6%N/A9.1 $13.98 12/15/202314,710,000 shares $200.94 million +9.0%N/A9.2 $13.66 11/30/202313,490,000 shares $184.81 million -2.7%N/A8.8 $13.70 11/15/202313,860,000 shares $187.53 million -0.1%N/A9.1 $13.53 10/31/202313,870,000 shares $197.09 million +5.8%N/A9.2 $14.21Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape. For the moment, you can watch this interview free of charge – just click here. 10/15/202313,110,000 shares $186.69 million -12.9%N/A8 $14.24 9/30/202315,050,000 shares $222.29 million +2.7%N/A9 $14.77 9/15/202314,660,000 shares $200.11 million +4.5%N/A8.4 $13.65 8/31/202314,030,000 shares $201.47 million -4.4%N/A7.7 $14.36 8/15/202314,670,000 shares $210.66 million -13.8%N/A8.2 $14.36 7/31/202317,020,000 shares $238.11 million -6.0%N/A9.5 $13.99 7/15/202318,110,000 shares $251.91 million -14.3%N/A11.6 $13.91 6/30/202321,140,000 shares $273.13 million +1.4%N/A14.3 $12.92 6/15/202320,840,000 shares $270.09 million +11.4%N/A15.7 $12.96 5/31/202318,700,000 shares $213.74 million +1.9%N/A15 $11.43 5/15/202318,360,000 shares $210.41 million +1.8%N/A13.2 $11.46 4/30/202318,040,000 shares $187.80 million -0.2%N/A13.1 $10.41 4/15/202318,070,000 shares $200.94 million -0.9%N/A12.8 $11.12 3/31/202318,230,000 shares $178.84 million +2.2%N/A12.6 $9.81 3/15/202317,840,000 shares $173.94 million +10.4%N/A12 $9.75 2/28/202316,160,000 shares $166.45 million -13.3%N/A10 $10.30 2/15/202318,640,000 shares $213.43 million +25.5%N/A11.7 $11.45 1/31/202314,850,000 shares $168.99 million +12.8%N/A9.1 $11.38 1/15/202313,170,000 shares $149.48 million +2.9%N/A7.5 $11.35 12/30/202212,800,000 shares $136.19 million -7.3%N/A7.2 $10.64 12/15/202213,800,000 shares $153.87 million -0.1%N/A7.4 $11.15 11/30/202213,820,000 shares $171.51 million -12.1%N/A7.4 $12.41 11/15/202215,730,000 shares $206.22 million +9.2%N/A8.5 $13.11 10/31/202214,400,000 shares $164.88 million -17.8%N/A6.8 $11.45 10/15/202217,520,000 shares $187.64 million +3.0%N/A8 $10.71 9/30/202217,010,000 shares $177.58 million +7.5%N/A8.2 $10.44 9/15/202215,830,000 shares $182.20 million +0.9%N/A7.7 $11.51 8/31/202215,690,000 shares $179.96 million -7.7%N/A7.5 $11.47 8/15/202217,000,000 shares $265.54 million -5.5%N/A7.3 $15.62 7/31/202217,990,000 shares $258.70 million -7.2%N/A6.1 $14.38 7/15/202219,380,000 shares $280.23 million +2.3%N/A6.8 $14.46 6/30/202218,950,000 shares $238.58 million -2.9%N/A6.6 $12.59 6/15/202219,510,000 shares $208.17 million +2.3%31.5%6.9 $10.67 5/31/202219,070,000 shares $226.17 million +8.2%N/A7 $11.86 5/15/202217,630,000 shares $169.25 million No ChangeN/A6.8 $9.60 4/30/202217,630,000 shares $155.67 million +3.0%N/A10.6 $8.83 4/15/202217,120,000 shares $179.93 million +1.0%N/A10.3 $10.51 3/31/202216,950,000 shares $183.74 million -0.7%N/A9.7 $10.84 3/15/202217,070,000 shares $178.21 million +3.3%N/A9.5 $10.44 2/28/202216,520,000 shares $202.54 million +2.2%N/A8.8 $12.26 2/15/202216,160,000 shares $215.25 million -0.9%14.6%8.7 $13.32 1/31/202216,310,000 shares $211.54 million +4.0%14.7%8.2 $12.97 1/15/202215,690,000 shares $212.29 million +1.2%N/A6.8 $13.53 12/31/202115,510,000 shares $218.23 million -5.5%13.9%6.6 $14.07 12/15/202116,420,000 shares $232.34 million +4.3%14.8%6.1 $14.15 11/30/202115,750,000 shares $254.36 million +3.5%14.2%4.4 $16.15 11/15/202115,220,000 shares $259.50 million -20.2%13.7%3.2 $17.05 10/29/202119,060,000 shares $380.63 million -3.4%17.2%3.9 $19.97 10/15/202119,730,000 shares $334.23 million -2.0%18.6%4.1 $16.94 9/30/202120,130,000 shares $386.70 million -5.9%19.0%4.4 $19.21Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape. For the moment, you can watch this interview free of charge – just click here. 9/15/202121,400,000 shares $309.87 million -7.8%20.2%4.9 $14.48 8/31/202123,200,000 shares $451.47 million +14.4%21.9%6.7 $19.46 8/13/202120,280,000 shares $267.70 million +1.2%19.2%9.3 $13.20 7/30/202120,050,000 shares $187.27 million +5.6%19.0%8.8 $9.34 7/15/202118,990,000 shares $179.27 million +4.6%18.0%8.6 $9.44 6/30/202118,150,000 shares $178.78 million +3.4%17.2%7.3 $9.85 6/15/202117,550,000 shares $156.02 million -0.6%16.6%7 $8.89 5/28/202117,660,000 shares $144.81 million -3.7%17.1%6.5 $8.20 5/14/202118,340,000 shares $134.43 million +14.1%N/A5.8 $7.33 4/30/202116,080,000 shares $168.20 million -14.0%N/A4.4 $10.46 4/15/202118,700,000 shares $189.62 million +1.7%N/A3.2 $10.14 3/31/202118,390,000 shares $171.39 million -16.2%N/A3.2 $9.32 3/15/202121,950,000 shares $210.28 million +7.8%N/A3.6 $9.58 2/26/202120,360,000 shares $166.14 million -4.0%N/A3.4 $8.16 2/12/202121,210,000 shares $202.13 million -5.3%N/A3.7 $9.53 1/29/202122,400,000 shares $132.16 million -4.7%N/A4 $5.90 1/15/202123,510,000 shares $120.84 million +2.9%N/A7.6 $5.14 12/31/202022,850,000 shares $111.97 million -6.4%N/A7.6 $4.90 12/15/202024,410,000 shares $126.20 million -8.8%N/A8.3 $5.17 11/30/202026,750,000 shares $128.13 million -2.9%N/A8.4 $4.79 11/15/202027,560,000 shares $114.65 million -4.2%N/A8.4 $4.16 10/30/202028,760,000 shares $112.16 million +8.5%N/A8.1 $3.90 10/15/202026,510,000 shares $121.68 million +1.8%N/A6.4 $4.59 9/30/202026,030,000 shares $112.45 million +44.5%N/A5.2 $4.32 9/15/202018,020,000 shares $96.41 million +5.0%N/A3 $5.35 8/31/202017,170,000 shares $102.68 million +1.1%N/A2.9 $5.98 8/14/202016,990,000 shares $114.17 million +2.9%N/A2.4 $6.72 7/31/202016,520,000 shares $133.98 million +22.3%N/A2.1 $8.11 7/15/202013,510,000 shares $124.16 million -11.4%N/A1.8 $9.19 DVAX Short Interest - Frequently Asked Questions What is Dynavax Technologies' current short interest? Short interest is the volume of Dynavax Technologies shares that have been sold short but have not yet been closed out or covered. As of June 15th, traders have sold 15,170,000 shares of DVAX short. 13.26% of Dynavax Technologies' shares are currently sold short. Learn More on Dynavax Technologies' current short interest. What is a good short interest ratio for Dynavax Technologies? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DVAX shares currently have a short interest ratio of 7.0. Learn More on Dynavax Technologies's short interest ratio. Which institutional investors are shorting Dynavax Technologies? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Dynavax Technologies: Goldman Sachs Group Inc., Caption Management LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Dynavax Technologies? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.26% of Dynavax Technologies' floating shares are currently sold short. Is Dynavax Technologies' short interest increasing or decreasing? Dynavax Technologies saw a drop in short interest in June. As of June 15th, there was short interest totaling 15,170,000 shares, a drop of 4.0% from the previous total of 15,800,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Dynavax Technologies' float size? Dynavax Technologies currently has issued a total of 120,080,000 shares. Some of Dynavax Technologies' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Dynavax Technologies currently has a public float of 114,400,000 shares. How does Dynavax Technologies' short interest compare to its competitors? 13.26% of Dynavax Technologies' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Dynavax Technologies: Alkermes plc (6.70%), Ligand Pharmaceuticals Incorporated (6.41%), BioCryst Pharmaceuticals, Inc. (11.59%), Amicus Therapeutics, Inc. (6.94%), Celldex Therapeutics, Inc. (12.34%), Innoviva, Inc. (15.56%), MannKind Corporation (8.23%), Novavax, Inc. (27.74%), OPKO Health, Inc. (8.85%), Geron Corporation (11.06%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Dynavax Technologies stock? Short selling DVAX is an investing strategy that aims to generate trading profit from Dynavax Technologies as its price is falling. DVAX shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Dynavax Technologies? A short squeeze for Dynavax Technologies occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DVAX, which in turn drives the price of the stock up even further. How often is Dynavax Technologies' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DVAX, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies Alkermes Short Interest Data Ligand Pharmaceuticals Short Interest Data BioCryst Pharmaceuticals Short Interest Data Amicus Therapeutics Short Interest Data Celldex Therapeutics Short Interest Data Innoviva Short Interest Data MannKind Short Interest Data Novavax Short Interest Data OPKO Health Short Interest Data Geron Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DVAX) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe $100 Trillion AI Story No One Is Telling YouJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredSomething very strange is happening...What a "Mar-a-Lago Accord" could mean for the U.S. dollar While protests dominate the news... hardly anyone...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dynavax Technologies Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Dynavax Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DVAX Stock Alerts